Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?
Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7
Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective
Estíbaliz Loza; Pedro Plazuelo; Ceade;
Reumatol Clin. 2023;19:273-8
Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up
Juan D. Cañete; Antonio Naranjo; Javier Calvo; Carmen Ordás; Belén Aragón; Gonzalo Nocea; Montse Roset; Antonio Fernández-Nebro;
Reumatol Clin. 2020;16:447-54